Portfolio company
JenaValve
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
3 investors
Sectors
About
This medical device company develops transcatheter heart valve replacement systems for patients suffering from symptomatic aortic regurgitation and aortic stenosis.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
CoreValve SA
This company develops trans-catheter aortic valve replacement systems for patients with severe aortic stenosis who are unsuitable for open-heart surgery.
Valcare Medical
The company develops transcatheter repair and replacement technologies for heart valves to treat patients with mitral and tricuspid regurgitation.
CoreMedic
This company develops transcatheter heart valve repair systems to treat mitral valve regurgitation for patients requiring minimally invasive cardiac interventions.
CroiValve
The company develops a transcatheter heart valve system to treat tricuspid regurgitation in patients unsuitable for open-heart surgery.
CroíValve
The company develops a minimally invasive transcatheter valve system to treat tricuspid regurgitation for elderly and frail cardiac patients.
CardioMech AS
This company develops catheter-based artificial chords to repair mitral valves for patients suffering from degenerative mitral regurgitation.
HighLife Medical
HighLife Medical develops transcatheter mitral valve replacement systems for patients suffering from moderate to severe mitral regurgitation.
HVR Cardio
This company develops transcatheter mitral valve repair devices to treat patients with mitral regurgitation.
